about
TGF-beta1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer.Cyclin F/FBXO1 Interacts with HIV-1 Viral Infectivity Factor (Vif) and Restricts Progeny Virion Infectivity by Ubiquitination and Proteasomal Degradation of Vif Protein through SCFcyclin F E3 Ligase MachineryMdm2 links genotoxic stress and metabolism to p53.Small molecules that inhibit Vif-induced degradation of APOBEC3G.HIV-1 and HIV-2 Vif interact with human APOBEC3 proteins using completely different determinantsHIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication.Immunogenetics of small ruminant lentiviral infectionsThe human transcriptome during nontyphoid Salmonella and HIV coinfection reveals attenuated NFkappaB-mediated inflammation and persistent cell cycle disruption.Identification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteinsThe HDAC6/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation.Host restriction factors in retroviral infection: promises in virus-host interaction.Interactions between HIV-1 Vif and human ElonginB-ElonginC are important for CBF-β binding to Vif.Arginine methylation increases the stability of human immunodeficiency virus type 1 Tat.Defining HIV-1 Vif residues that interact with CBFβ by site-directed mutagenesis.Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.HIV-1, ubiquitin and ubiquitin-like proteins: the dialectic interactions of a virus with a sophisticated network of post-translational modifications.Clues for two-step virion infectivity factor regulation by core binding factor beta.HIV-1 Tat potently stabilises Mdm2 and enhances viral replication.Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation.Dynamical properties and thresholds of an HIV model with super-infection.HIV-1 Vif: a guardian of the virus that opens up a new era in the research field of restriction factorsPolyubiquitination of APOBEC3G is essential for its degradation by HIV-1 Vif.Hijacking of the Ubiquitin/Proteasome Pathway by the HIV Auxiliary Proteins.Introduction of H2C2-type zinc-binding residues into HIV-2 Vpr increases its expression level.Post-translational Modification-Based Regulation of HIV Replication
P2860
Q33559621-53DC6338-2577-424A-AF7A-D7A654EC8F72Q33567848-66451132-2069-43B0-80F0-341639E32EFEQ33788018-C4F5DDA2-283A-4B17-A01F-F3518236BBC0Q33857983-D6A1F79A-D9A8-40D3-B306-AA7CB0C9D96AQ34059564-F6400866-181A-441C-9DA1-F644BCB7D6F6Q34376092-B970081F-8C3A-4CED-9419-4703895E4715Q34434913-404BD1BD-473C-435D-AB59-E3400A46DEDBQ35214153-324F5B3F-BECE-4C5A-91FC-E0F75EEEAD32Q35531709-37210829-21D5-4E86-B138-D3884609FC2FQ35776289-1266D3C4-BFBC-45BF-A8FC-2D746A5B0491Q36548179-11416968-A1DF-4EC4-945A-E4F6EE4A2391Q37153444-04A3EFA4-10E3-45AB-91E6-82D303074CD1Q37410634-9561F1E1-6B62-44BD-AA1D-580FFCB8E310Q37605560-5F99DBAB-51E4-4259-B8BE-AC858217FF1EQ37950254-252D611F-01B6-45DE-A9DB-071E054252EFQ37970436-7F440FBB-E127-4F7C-A4CF-44ED57E45E4DQ38703114-9EFD69C9-FAC3-44F7-9560-518CED4B3A79Q38705008-8F4AFC6E-1FE2-4DE6-AD76-19FC4BF5A31DQ38739726-503B995B-88BE-4373-8FB4-D4F4E1C02E1BQ39208948-C342C754-5BEA-4934-AB56-E2A81BD24481Q39463408-71F5E6D8-9DF8-46DD-89F0-EED7C7252C5AQ39741166-559332B8-F29D-4E66-B1E2-F42DD272F5BFQ47138132-94FDCEB7-4F0D-4192-AE8C-64CE3E338D28Q47555671-E78B0883-D4D0-471C-A582-DDEA317ECF56Q58750447-D24CA90C-6A26-4465-BF1C-A5EF3BE3D11D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MDM2 is a novel E3 ligase for HIV-1 Vif.
@en
MDM2 is a novel E3 ligase for HIV-1 Vif.
@nl
type
label
MDM2 is a novel E3 ligase for HIV-1 Vif.
@en
MDM2 is a novel E3 ligase for HIV-1 Vif.
@nl
prefLabel
MDM2 is a novel E3 ligase for HIV-1 Vif.
@en
MDM2 is a novel E3 ligase for HIV-1 Vif.
@nl
P2093
P2860
P50
P356
P1433
P1476
MDM2 is a novel E3 ligase for HIV-1 Vif
@en
P2093
Akifumi Takaori-Kondo
Hiroaki Higashitsuji
Hiroshi Kondoh
Jun Fujita
Katsuhiko Itoh
Katsuhiro Io
Kotaro Shirakawa
Masashi Matsui
Mitsunori Tomonaga
Satoru Ikeda
P2860
P2888
P356
10.1186/1742-4690-6-1
P577
2009-01-07T00:00:00Z
P5875
P6179
1046051363